Sara Miqueleiz
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 13
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 3
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 9
-
- Immunodeficiency and Autoimmune Disorders 4
-
- Viral-associated cancers and disorders 2
-
- Acute Lymphoblastic Leukemia research 5
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- COVID-19 Clinical Research Studies 2
In The Last Decade
Sara Miqueleiz
17 papers receiving 262 citations
Peers
Comparison fields: 5 of 46
- Genetics 179
- Hematology 93
- Pathology and Forensic Medicine 147
- Immunology 98
- Oncology 41
Countries citing papers authored by Sara Miqueleiz
This map shows the geographic impact of Sara Miqueleiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Miqueleiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Miqueleiz more than expected).
Fields of papers citing papers by Sara Miqueleiz
This network shows the impact of papers produced by Sara Miqueleiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Miqueleiz. The network helps show where Sara Miqueleiz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara Miqueleiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 12 | |
| 3 | 2009 | 1 | |
| 4 | 2008 | 4 | |
| 5 | 2007 | 1 | |
| 6 | 2007 | 9 | |
| 7 | 2007 | 1 | |
| 8 | 2007 | 9 | |
| 9 | 2006 | 111 | |
| 10 | 2005 | 10 | |
| 11 | 2005 | 24 | |
| 12 | 2005 | 2 | |
| 13 | 2005 | 1 | |
| 14 | 2004 | 33 | |
| 15 | 2004 | 10 | |
| 16 | 2003 | 12 | |
| 17 | Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules. | 2003 | 31 |
About Sara Miqueleiz
Sara Miqueleiz is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 17 papers that have together received 272 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Viral-associated cancers and disorders (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Genetics (179 citations), Hematology (93 citations) and Pathology and Forensic Medicine (147 citations). Sara Miqueleiz has collaborated with scholars based in Italy and Spain. Frequent co-authors include Enrica Morra, Francesca Ricci, Clara Cesana, Alessandra Tedeschi, Luciana Barbarano, Marco Montillo, Mario Regazzi, Michele Nichelatti, Michela Montagna and Silvio Veronese. Their work appears in journals such as Journal of Clinical Oncology, Blood and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.